Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rovatirelin (S-0373) is a newly synthesized thyrotropin-releasing hormone (TRH) analog that ameliorates cytosine arabinoside-induced motor dysfunction in a rat model of spinal cerebellar degeneration via acetylcholine and dopamine neurotransmission.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 373.00 | |
5 mg | In stock | $ 893.00 | |
10 mg | In stock | $ 1,220.00 | |
25 mg | In stock | $ 1,820.00 | |
50 mg | In stock | $ 2,380.00 | |
100 mg | In stock | $ 3,100.00 |
Description | Rovatirelin (S-0373) is a newly synthesized thyrotropin-releasing hormone (TRH) analog that ameliorates cytosine arabinoside-induced motor dysfunction in a rat model of spinal cerebellar degeneration via acetylcholine and dopamine neurotransmission. |
Synonyms | KPS-0373, S0373, S-0373, S 0373 |
Molecular Weight | 366.43 |
Formula | C16H22N4O4S |
CAS No. | 204386-76-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rovatirelin 204386-76-5 Neuroscience AChE KPS-0373 S0373 S-0373 S 0373 inhibitor inhibit